Medlive Technology Co (2192.HK) Stock Price
Medlive Technology Co Price
Revenue has compounded at 33.8% per year over the past 7 years to 747.32 M CNY. Earnings per share have grown at 55.7% per year over the last 7 years. Medlive Technology Co's net margin stands at 52.1%, up from 14.3% several years earlier. Medlive Technology Co currently offers a dividend yield of about 4.89%. The payout ratio is around 44% of earnings. The dividend has grown at 136.3% per year over the past 3 years. Analysts set a median price target of 13.08 CNY, implying 132.2% above the current price. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus.
Medlive Technology Co stock price
Medlive Technology Co business model & stock analysis
Frequently asked questions about Medlive Technology Co
Analysts currently set an average price target of 13.14 CNY for the Medlive Technology Co stock (median: 13.08 CNY), implying +133.2 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Medlive Technology Co stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Medlive Technology Co to generate revenue of 721.19 M CNY and earnings per share of 0.47 CNY.
Converted at the current exchange rate, the Medlive Technology Co share trades at 0.75 EUR (5.63 CNY).
The Medlive Technology Co share (2192.HK) is listed on 1 stock exchanges, including: Hongkong (HKEX) (2192.HK).
The expected revenue of Medlive Technology Co is 721.19 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Medlive Technology Co is 344.03 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medlive Technology Co is currently 12.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medlive Technology Co stock.
The price-to-sales ratio (P/S) of Medlive Technology Co is currently 5.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medlive Technology Co stock.
The Eulerpool Quality Score for Medlive Technology Co is 4/10.
The ISIN of Medlive Technology Co is KYG5961B1041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medlive Technology Co is 2192.HK. The ticker symbol is used to trade Medlive Technology Co shares on the stock exchange.
Medlive Technology Co stock
Medlive Technology Co Peer Group
Medlive Technology Co Ticker
Medlive Technology Co FIGI
All fundamentals and in-depth analysis of Medlive Technology Co
Our stock analysis for Medlive Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medlive Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.